Celltrix is a Swedish biotechnology/medical device company focusing on reconstructive cosmetic surgery. Research, development and production are based in Malmö. We plan to launch the first product —Credurance — in 2010.
Our product represents a new type of dermal filler. An immediate filling effect is achieved and the surrounding cells are presented to a matrix suitable for cell growth. As the cells grow on and inside the matrix, they produce their own environment, natural collagen, which gradually replaces the matrix – biorestoring.
LATEST NEWS
2009-12-14
PRESS RELEASE
Celltrix AB, a Swedish medical device company, has signed a 12 MSEK agreement with SEED Capital Denmark K/S, Malmöhus Invest AB and Lumitec AB.
The new investment will be used to finalize a clinical trial in humans leading to CE-registration and market introduction of Celltrix first product, the cosmetic filler Credurance.
Read more>>